Semaglutide 5 mg

BELIGAS PHARMACEUTICALS SEMAGLUTIDE

Semaglutide, a groundbreaking glucagon-like peptide-1 receptor agonist, is presented in a 5 mg formulation meticulously crafted by Beligas Pharmaceuticals. Designed to manage blood sugar levels in patients with type 2 diabetes, Semaglutide offers a potent and innovative solution in the realm of antidiabetic medications.

DRUG COMPOSITION

The active substance in Semaglutide is Semaglutide itself, a synthetic peptide with properties akin to the naturally occurring glucagon-like peptide-1 (GLP-1).

PHARMACEUTICAL FORM

Semaglutide is presented in a convenient powder form, providing a reliable and effective means of administration for individuals seeking glycemic control.

PHARMACEUTICAL GROUP AND ATC CODE

Semaglutide falls under the category of antidiabetic medications and is classified under the Anatomical Therapeutic Chemical (ATC) code, though specific coding may vary.

PHARMACOLOGICAL PROPERTIES

Semaglutide mimics the action of GLP-1, promoting insulin secretion, inhibiting glucagon release, slowing gastric emptying, and promoting a feeling of fullness. These actions collectively contribute to improved blood sugar control and weight management.

PROFILE

• Chemical name: Semaglutide
• Chemical formula: C187H291N45O59
• Percentage of anabolic activity: Not applicable (not an anabolic steroid)
• Percentage of androgenic activity: Not applicable
• Active half life: Approximately 1 week
• Recommended dosage: Varies, typically once weekly
• Acne: Not a known side effect
• Bloating (water retention): Not a known side effect
• HBR: Not applicable
• Hepatic toxicity: Not a known side effect
• Aromatization: Not applicable

THERAPEUTICAL INDICATIONS

Semaglutide is indicated for the management of type 2 diabetes mellitus in adults, either as monotherapy or in combination with other antidiabetic medications.

DOSES AND METHOD OF ADMINISTRATION

• Standard Dosage: 5 mg once weekly
• Administration: Subcutaneous injection
• Frequency: Weekly

CYCLE/STACKING

Solo Cycle:

• Dosage: 5 mg once weekly
• Cycle Length: Continuous

Cutting Cycle:

• Stack: Semaglutide with Metformin
• Dosages: Semaglutide (5 mg once weekly), Metformin (dosage as prescribed)
• Cycle Length: Continuous

Bulking Cycle:

• Stack: Semaglutide with Insulin
• Dosages: Semaglutide (5 mg once weekly), Insulin (dosage as prescribed)
• Cycle Length: Continuous

POST CYCLE THERAPY

No specific PCT is required for Semaglutide. Patients should continue their regular antidiabetic regimen under the guidance of a healthcare professional.

SIDE EFFECTS

Common side effects may include nausea, vomiting, diarrhea, and transient gastrointestinal discomfort. Hypoglycemia may occur, particularly when combined with insulin or sulfonylureas.

CONTRAINDICATIONS

Semaglutide is contraindicated in patients with a history of hypersensitivity to Semaglutide, personal or family history of medullary thyroid carcinoma (MTC), and multiple endocrine neoplasia syndrome type 2 (MEN 2).

OVERDOSE

Excessive doses may increase the risk of hypoglycemia. Dosing should be done according to prescribed guidelines.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Semaglutide should be used cautiously in patients with a history of pancreatitis, renal impairment, and in elderly patients. Regular monitoring is advised.

INTERACTIONS WITH OTHER DRUGS

Semaglutide may interact with certain oral medications. Consultation with a healthcare professional is recommended before combining medications.

PRESENTATION, PACKAGING

5 mg per mL in 10 mL vials.

STORAGE

Store Semaglutide in accordance with the manufacturer's instructions, typically in a cool and dry place.

DELIVERY TO THE USA

Steroid.biz ensures secure and discreet delivery to the USA, ensuring timely access to Semaglutide.

LEGAL STATUS

Semaglutide is a prescription medication approved for use in managing type 2 diabetes mellitus. It should be used under the guidance of a qualified healthcare professional.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Beligas Pharmaceuticals
USA

EXTERNAL LINKS

• Semaglutide Wiki, wikipedia.org
• Semaglutide: uses, dosage, side effects, brands, drugs.com
• Semaglutide Injection: MedlinePlus Drug Information, medlineplus.gov.